Can highly regulated pharmaceutical companies use AI effectively? What are companies doing to leverage AI without compromising their CGMP-validated processes? Please join this practical, real-world conversation on moving AI in pharma beyond pilots and into meaningful results. Tech-Clarity’s Julie Fraser joins a panel discussion with Sam Laermans, Global AI Lead at NNIT, Senior IT Leader…
